Marian Nakada
Using BIG for GOOD. Making strategic investments for Johnson & Johnson Innovation - JJDC
Cambridge, Massachusetts
Invests in
Sectors:
Locations:
Min Investment:
$0.00Max Investment:
$0.00Target Investment:
$0.00
Skills
Education
- HU
- Uo
Lists including Marian
Investments
Work Experience
2024
Board Observer
2024
2013
Vice President, Venture Investments JJDC
2013
Focuses on pharmaceutical venture investments on the East Coast, in support of Janssen R&D objectives. Works closely with Boston Innovation Center colleagues, Therapeutic Areas and cross-R&D Functional Areas.
2019
Advisor
2019
Provide input to shape the themes, topics and speakers for the Convergence Forum
2021
Member
2021
2021
Board Observer
2021
2019
Board Member
2020
Board Chair
2019 - 2020
2013
Board Member
2013
2016 - 2023
Board Member
2016 - 2023
The NEVCA fosters a collaborative, inclusive, and prosperous innovation ecosystem on behalf of New England's VC industry. Operating across four pillars - Venture Community, Regional Brand, Workforce Development, and Public Policy - the association's initiatives impact the community at large: events connect founders, funders, and innovators; legislative advocacy promotes economic growth; programs bolster professional development across the venture landscape.
2018 - 2023
Board Member
2018 - 2023
Twentyeight-Seven Therapeutics is focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases. By targeting ncRNA modulating proteins (RMPs), we can use small molecules to modulate expression levels of oncogenes and other proteins of significance in disease.
2014 - 2021
Board Observer
2014 - 2021